Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：192

作者：

Aebi, S. ^{[1
,2
]}

Davidson, T. ^{[3
,4
]}

Gruber, G. ^{[5
]}

Cardoso, F. ^{[6
,7
]}

机构：

[1] Kantonsspital, Div Med Oncol, Luzern, Switzerland

[2] Univ Bern, Dept Med Oncol, CH-3012 Bern, Switzerland

[3] Royal Free Hampstead NHS Trust, Univ Dept Surg, London, England

[4] Univ Coll Med Sch, London, England

[5] Klin Hirslanden, Inst Radiat Therapy, Zurich, Switzerland

[6] European Sch Oncol, Milan, Italy

[7] Champalimaud Canc Ctr, Breast Canc Unit, Lisbon, Portugal

来源：

ANNALS OF ONCOLOGY | 2011年 / 22卷

关键词：

SURGICAL ADJUVANT BREAST; ESTROGEN-RECEPTOR STATUS; INDUCED BONE LOSS; ZOLEDRONIC ACID; PREMENOPAUSAL WOMEN; POSTMENOPAUSAL WOMEN; ENDOCRINE THERAPY; RANDOMIZED-TRIAL; PHYSICAL-ACTIVITY; AMERICAN SOCIETY;

D O I：

10.1093/annonc/mdr371

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：vi12 / vi24

页数：13